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Hypertension affects an estimated 1.4 billion people and is a major cause of morbidity
and mortality worldwide. Early diagnosis and intervention can potentially decrease
cardiovascular events later in life. However, blood pressure (BP) measurements take
time and require training for health care professionals. The measurements are also
inconvenient for patients to access, numerous daily variables affect BP values, and only
a few BP readings can be collected per session. This leads to an unmet need for an
accurate, 24-h continuous, and portable BP measurement system. Electrocardiograms
(ECGs) have been considered as an alternative way to measure BP and may meet this
need. This review summarizes the literature published from January 1, 2010, to January
1, 2020, on the use of only ECGwavemorphology to monitor BP or identify hypertension.
From 35 articles analyzed (9 of those with no listed comorbidities and confounders), the P
wave, QTc intervals and TpTe intervals may be promising for this purpose. Unfortunately,
with the limited number of articles and the variety of participant populations, we are
unable to make conclusions about the effectiveness of ECG-only BP monitoring. We
provide 13 recommendations for future ECG-only BP monitoring studies and highlight
the limited findings in pregnant and pediatric populations. With the advent of convenient
and portable ECG signal recording in smart devices and wearables such as watches,
understanding how to apply ECG-only findings to identify hypertension early is crucial to
improving health outcomes worldwide.
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INTRODUCTION
Hypertension is a major cause of morbidity and mortality
(1) and affects an estimated 1.4 billion people worldwide
(2). Hypertension is defined as blood pressure (BP) that is
elevated above 130 mmHg systolic or above 80 mmHg in
stage 1 and above 140 mmHg or above 90 mmHg in stage 2
by the American College of Cardiology and American Heart
Association (3). Long term consequences of hypertension can
include ischemic heart disease, stroke, and end stage renal disease
(1). Cardiac structural changes from prolonged hypertension
can lead to arrhythmia and sudden cardiac death (4). Managing
BP early, even at prehypertensive levels, may decrease the
incidence of cardiovascular events later in life (5). Recognizing
and intervening in acute BP emergencies can also decrease
mortality (6). Hypertensive conditions in pregnancy, such as pre-
existing hypertension, gestational hypertension, preeclampsia,
and eclampsia, can lead to perinatal and maternal morbidity and
mortality (7). All of these findings highlight the importance of
having an effective BP surveillance system.
Prehypertension and primary hypertension can be difficult
to identify, as their diagnosis relies on BP readings (3).
Conventionally, BP is measured using an auscultatory
sphygmomanometer or automated oscillometric devices in
health care settings or with oscillometric devices at home (3).
Obtaining accurate BP measurements are challenging as it
is necessary to coordinate multiple factors with the patient
such as ensuring the patient has emptied their bladder, has
relaxed for at least 5min and has avoided smoking, exercise,
and caffeine 30min prior (3). Furthermore, the BP cuff, the
BP device type, the measurer’s technique, and the frequency
of BP measurements also need to be considered (3). These
measurements take time and training for health care providers
and are inconvenient for patients who need to visit a doctor’s
office or learn to manage their own BP monitoring at home.
In addition, errors in BP readings are made by both physicians
and patients (8, 9). Even if health care providers and patients
meet all the measurement guidelines, the measurement methods
only capture a few instantaneous readings of BP for analysis.
Further, numerous daily variables can affect BP from moment
to moment (3, 8, 10). This is concerning, as even a 5 mmHg
difference to the measurement can change a patient’s BP category
and management plan (10). Thus, there is an unmet need for an
accurate, 24-h continuous and portable BP measurement system.
There has been ongoing work to develop alternative, more
convenient ways of measuring BP using photoplethysmography
Abbreviations: AC Filter, Alternating Current Filter; AV Conduction,
Atrioventricular Conduction; BMI, Body Mass Index; BP, Blood Pressure;
DBP, Diastolic Blood Pressure; ECG or EKG, Electrocardiogram; HRV, Heart
Rate Variability; HT, Hypertensive; Hz, Hertz; LAE, Left Atrial Enlargement;
LVDD, Left Ventricular Diastolic Dysfunction; LVH, Left Ventricle Hypertrophy;
mmHg, Millimeter of Mercury; ms, Milliseconds; NR, Not Reported; NS, Not
Significant; NT, Normotensive; PHT, Prehypertensive; PIHT, Pregnancy-Induced
Hypertension; PPG, Photoplethysmography; QTc, QT interval corrected for heart
rate using Bazett’s formula: QT/
√
R –R (11), or Hodges formula: [QTc = QT +
1. 75 (heart rate – 60)] (12); QTd, QT Interval Dispersion; SBP, Systolic Blood
Pressure; STD, Standard Deviation; TpTe, Length between peak of T wave to the
end of the T wave (13).
(PPG) and electrocardiograms (ECGs or also known as EKGs)
(14–18). These methods range from using a single biomedical
signal to assess BP (17), to using multiple body sites with PPG
input (15), to using PPG along with another type of input such as
ECGs (18). However, measuring BP using only ECG signals has
not been reviewed. The aim of our review is to identify if there
are specific ECG features that could be used alone to measure BP
or identify hypertension.
Note that the ECG waveform can provide valuable
information about the heart status. The waveform features
can be analyzed to determine, for example, heart rate variability
and left ventricular hypertrophy. It can also be used to design
machine-learning algorithms for other BP studies. Links between
hypertension and such biomedical signals may show promise for
monitoring BP.
It is hypothesized that elevated heart rates represent persistent
sympathetic activation, which leads to increases in BP and
cardiovascular complications (19). Heart rate variability (HRV)
can be estimated from ECG signals and can reveal whether there
is dysregulation of the autonomic system leading to a decrease in
the ability to return to lower heart rates (19, 20). HRV may show
some promise in monitoring hypertension and poor pregnancy
outcomes as HRV has been found to decrease as BP increases
(20–24). However, HRV can be measured in different ways and
requires its own review outside of this paper.
Left ventricular hypertrophy (LVH) is thought to be an
adaptive response to hypertension and is found in a small portion
of hypertensive patients at 5–18% using ECG signals (23, 25). It
has been used to predict dangerous cardiac arrhythmia and other
cardiovascular risks in hypertensive patients (23, 25). Note that
LVH is generally a long term complication for elevated BP over a
long period of time (4), which maymake it less promising finding
to identify new onset hypertension.
Some early work has looked at using machine-learning to
identify ECG signal features that can potentially categorize
individuals as high-risk hypertension (SBP ≥ 130, DBP ≥ 80)
or low-risk hypertension (SBP < 130, DBP < 80) (26). Note
that authors did not mention the logical operation between
the SBP and DBP, in other words it was not clear if it is an
“OR” or “AND” between them. ECG signal components may be
mapped (or interpreted) into a quantitative number based on
machine-learned algorithms and considered for the identification
of and monitoring of chronic conditions (i.e., pulmonary artery
hypertension, hypertension, coronary artery disease, etc.) (27).
Additionally, ECG signal components may be categorized into
hypertension (SBP ≥ 140 OR DBP ≥ 90), prehypertension (SBP
= 120–139 OR DBP = 80–89) or normal BP (SBP < 120 AND
DBP < 80) and then machine learning with this categorization
may predict specific BP values for individuals (28). However,
there are few studies in this field to draw conclusions from at
this time.
This review focuses on analyzing ECG wave morphology
without HRV, LVH or machine learning. ECG wave morphology
has been a promising area of investigation related to hypertensive
individuals. In a review of ECG parameters in the context
of hypertension and arrhythmia risk, P wave duration and
QT dispersion were noted to have decreased after BP was
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controlled with medication (23). In addition, T wave amplitudes
have been noted to differ between hypertensive patients and
normotensive individuals (23) However, there have been no
detailed reviews specifically looking at ECG wave morphology
differences between hypertensive and normotensive individuals.
Interestingly, ECG wave morphology changes can happen over
a short period of time, such as from before to after treatment
of a hypertensive crisis (29). Therefore, ECGs may provide 24-
h continuous opportunity for monitoring of hypertension and
for alerting patients and their health care providers to acute
conditions, such as hypertensive emergencies or preeclampsia.
In this current review, we conducted a search of literature
published from the last decade on the use of only ECG wave
morphology to either measure BP or identify hypertension. The
aim of this review is to summarize the current understanding of
monitoring BP, identifying hypertension using only ECG wave
morphology and provide an effective BP surveillance system. We
set our ultimate review question to be: can we use only ECG wave
morphology to measure BP or identify hypertension in humans?
METHODS
Search Strategy
On March 27, 2020, we searched PubMed for articles with
keywords related to ECGwavemorphology and BPmeasurement
using “AND.” We also included “EKG” as a keyword as it is
equivalent to ECG. We filtered our searches to focus on the
title/abstract. We searched the last 10 years (January 1, 2010, to
January 1, 2020) to determine the current understanding of the
topic. These initial searches resulted in 2,951 articles.
We excluded any articles that were reviews, case studies, or
commentaries. We also filtered out any articles that were not in
English. As we focus on only ECGs, we used “NOT” to remove
articles with words related to photoplethysmography technology,
which we are aware has been used in combination with ECGs
to measure BP. To narrow the search to articles looking at
ECG wave morphology as a way to measure BP, we identified
ECG parameter related words in a quick exploratory literature
search and combined these words with “AND.” The exact search
terms are described in Appendix 1, and the final search entry is
described in Appendix 2.
Study Selection and Study Data Extraction
From January 1, 2010, to January 1, 2020, we identified 719
articles from our search. We then hand-selected articles if their
title or abstract indicated that their primary aim was to use only
ECG wave morphology to measure BP or identify hypertension.
If ECGs were combined with another method, we did not select
the article. The flowchart of the inclusion and exclusion is shown
in Figure 1.
Several articles mentioned prediction of a future diagnosis of
hypertension or assessment of participants with hypertension to
predict if they are at low or high risk for complications from
hypertension, such as myocardial infarction, stroke, or atrial
fibrillation. We did not select these articles as we are not looking
to predict hypertension or strategize about the risk of those with
hypertension. Instead, we focus on measuring BP or diagnosing
hypertension in the present. We also did not select articles which
used non-clinical ECG features such as ECG segments found
through machine learning. We are interested in ECG features
that can be identified in the clinical setting.
We selected articles in which participants were recruited from
the general population or based on their blood pressure. We
avoided articles that selected their participant populations based
on other medical conditions, such as diabetes mellitus, metabolic
syndrome or obesity (defined as Body Mass Index (BMI) over
30 kg/m²) (30). This was done to avoid confounding medical
conditions that may alter ECGmorphology.We also used articles
with human participants of any age to gain a comprehensive
understanding of the age groups that have been studied.
In total, 36 articles that fit our inclusion criteria and are
listed in Appendix 3. We fully read 36 articles and extracted
data regarding the participants (e.g., sample size, sex, and age),
BP measurement systems, ECG parameter estimation methods,
and the articles’ conclusions about the significance of ECG
wave parameters. We collected all participant data up to one
decimal place and all p-values up to four decimal places if they
were available.
Based on our review, there were two main ways to measure
BP: cuffed with discrete measurements and cuffless with
continuous measurements. We listed if each study used a
cuffed or cuffless method in the table in Appendix 3. For the
cuffed measurements, they were intermittent and non-invasive
using a cuff to collect a discrete BP measurement at set time
points. All the articles used cuffed measurements. One article
used a cuffed method and confirmed if individuals were
hypertensive or normotensive with the cuffless method.
The cuffless method used a continuous and invasive
method by cannulating the radial artery for inter-arterial
BP measurements (31).
For the BP categorization of participants, some articles
had different definitions of hypertension, prehypertension
and normotension and some articles grouped participants
just by different increments of BP measurements. We listed
the definitions of BP categorization used in each article in
Appendix 3. One study had data for both SBP and DBP (13). We
used the SBP p-values from this article.
For ECG parameter estimation methods, we categorized
them as either “manual” (when the study specifically said
they used “manual” methods, used physical instruments such
as paper, calipers, rulers or when multiple individuals were
involved in estimating ECG parameters), “Computed” (when
computer software automatically estimated ECG parameters),
“mixed” (when both manual and digital methods were involved
in estimating ECG parameters; not including when individuals
simply checked if the ECG recording was of satisfactory quality)
or “NR” (when the details were not reported or if it was unclear if
manual or computed methods were used).
There were two articles with the same first author that had
identical participant numbers, and ECG results. We removed
one of these articles to avoid adding duplicate data into our
review. This removed article is listed after the included article
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FIGURE 1 | Flowchart of the article search, screening, and selection process.
in Appendix 3. All 36 articles were reviewed and verified and 35
articles were used for analysis.
Data Analysis
Using the extracted data, we grouped the 35 articles’ findings into
tables based on ECG wave parameter type. We then analyzed the
articles based on their sample size, the participants’ comorbidities
and confounders, the number of participants in each BP class,
the definitions the articles used to categorize BPs, the gold
standard the articles used tomeasure BPs, the ECG leads used, the
sampling frequency, how ECG parameters were estimated and
the participants’ position during BP and ECG signal collection
(i.e., sitting, supine, etc.). If the participant data was split up
into different subgroups, such as by BP categorization, we
used the following Cochrane formula to combine mean and












1 +M22 − 2M1M2)
N1 + N2 − 1
,
where, x̄p is pooled mean, x̃p is pooled standard deviation, N1is
the number of participants in the first group, N2 is the number
of participants in the second group that is being combined with
the first group, M1 is the mean value of x in the first group, M2
is the mean value of x in the second group, SD1 is the standard
deviation for the first group and SD2 is the standard deviation
for the second group. When there were more than two groups to
combine, the first and second group would be combined. Then
the resulting value would be considered as a “new” first group.
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The third group would then be considered as a “new” second
group for the application of the above formulas.
There was one article by Anigbogu et al. (33) which seemed
unclear if a figure was missing indicators of significant results
for certain ECG parameters. We added double asterisk to the
ECG parameters in question in Appendix 3 and have treated the
results as not significant.
With each ECG wave parameter, we first analyzed the overall
theme of the article, such as if there was a consensus on whether
the features of the parameter had a significant ability to predict
SBP or DBP or to identify individuals with elevated BP. We
considered an article to have a significant result if the p-value
was less than 0.05. For cases when there were two or less articles
regarding a certain feature, then this feature was not analyzed
due to the scarcity of the number of studies. For example, the
P wave duration was only investigated by two articles that yielded
confounding results; thus, resulting in a lack of identifiable
patterns. Contrarily, the P wave maximum was investigated by
10 separate studies which granted the opportunity to analyze the
findings and determine whether there was a consistent pattern
demonstrating ECG changes in hypertensive patients.
Second, we grouped articles based on whether the participants
had comorbidities such as diabetes mellitus, metabolic syndrome,
and an average BMI in the obese range as described earlier.
We also considered confounders, such as whether participants
smoked or had significant differences in alcohol consumption,
age, BMI or sex, as these variables have been noted to alter
ECGs (34–41). Ultimately, we looked at whether there was a
difference in the findings when there were known comorbidities
and confounding factors present and when the participants were
healthy with no comorbidities or confounding factors. When
we only analyzed articles without comorbidities or confounders,
there were only eight articles present, so we focused on features if
there were two or more articles finding significance to be able to
provide results with this point of view.
Third, we investigated the groupings of articles with pregnant
participants and with pediatric participants. This was done to
determine if there were any promising ECG parameters in
these populations.
Fourth, we investigated groupings of ECG parameters (i.e.,
atrial and ventricular parameters) to determine if there was
a consensus about whether elevated BPs are more commonly
present with atrial or ventricular changes. We focused on using
data from articles without comorbidities or confounders.
Fifthly, we listed how many leads were used in each study. If a
specific lead was focused on for an ECG parameter, we also listed
this in our tables. This is to investigate if significant results can be
obtained from using fewer leads than a standard 12-lead ECG.
Finally, we categorized each article by if they used manual,
digital, mixed or did not report how their ECG parameters were
estimated. We investigated if there was a trend in how ECG
parameters were being estimated.
Hypothesis
We hypothesize that our review will find ECG parameters
that are consistently differentiated between normotensive and
hypertensive individuals.
RESULTS
Between January 1, 2010, and January 1, 2020, we selected 36
articles and analyzed 35 articles which investigated the use of
only ECG wave morphology parameters (not HRV indices, LVH
measurements or machine learning) to measure BP or identify
hypertension. Two articles had identical participant numbers and
ECG results, so one of these articles was removed. Appendix 3
presents the full list of the 35 articles analyzed in this paper and
the one removed article. Appendix 4 groups the articles based
on their ECG wave parameter findings. Based on the analyzed
articles, a summary of commonly used ECG features for assessing
hypertension is shown in Figure 2. The definition of each feature
is described in Table 1.
Comparing ECG Wave Morphology
There were 14 articles that investigated P wave features, as
seen in Table A. Note that P wave maximum and dispersion
were the most commonly investigated features, with ten articles
each. In seven of the 10 articles, P wave dispersion was found
to be significantly greater with elevated BP. The three non-
significant articles had lower average BMIs (22.7, 26.1, not
reported vs. 23.9 to 29.7 in significant articles), populations who
had comorbidities excluded, participants only recently diagnosed
with hypertension, or did not have hypertensive participants
(13, 42, 56). In five of the 10 articles, the P wave maximum was
significantly higher with elevated BP. The five articles with the
differences between HT participants and NT participants noted
differences ranging from 2.8 to 23.3ms (44, 58–61). The non-
significant articles had populations that had younger average ages
(22.7 to 51.6 vs. 44.7 to 53.6 years old), healthier with none or
less comorbidities listed, and all of them were recently diagnosed
with hypertension or did not have hypertensive participants
(13, 42, 56, 62, 63). The Pwaveminimumwas the least significant,
with only one article of seven reporting a significant finding. P
wave duration, prolongation, area, amplitude, and terminal force
were all investigated by two or fewer articles. It can be seen that
PR intervals were significantly longer with increased BP in two
of six articles, as shown in Table B. The four studies that were
non-significant had populations which were generally younger
22.7, 42.8, 56.0, and not reported compared to 54.2 and 55.6
years old, had lower BMIs 22.7 to 26.5 compare to 28.2, had
healthier participants with comorbidities removed and three of
the four had participants with newly diagnosed hypertension or
no participants with hypertension (13, 33, 42, 45).
QT and QTc intervals were included in 15 articles, as shown
in Table C. In three of four articles, QT dispersion was found
to be significantly larger with higher BP. An example of the
most substantial difference was an article with a mean QT
dispersion of 65.6ms for HT participants and 38.7ms for NT
participants (46). The article that did not find significance had
a younger population average age of 28.2 years old vs. 42.8,
56.0, and 57.4 years old (56). QT duration was not significant
in three out of three studies. Two or fewer articles looked
at other QT features, such as QT maximum, QT minimum,
and abnormal QT dispersion. The most articles analyzed QTc
duration, and five of nine articles found it was significantly
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TABLE 1 | Summary of ECG wave morphology parameter definitions.
Feature Definitions
P wave maximum Longest P wave across all leads (in milliseconds) (13)
P wave minimum Shortest P wave across all leads (in milliseconds) (42)
P wave duration Average P wave duration in each all lead (in milliseconds) (42)
P wave prolongation P wave longer than 120ms (43)
P wave dispersion Difference between P wave maximum and P wave minimum (in milliseconds) (13)
P wave area Total area under and above the isoelectric line from the beginning to the end of the P wave (13)
OR
The product of P-wave amplitude per half of lead II duration (42)
P wave amplitude Amplitude of P wave (in millivolts) (42)
P wave terminal force “Product of the duration (in seconds) and amplitude (in millimeters) of the negative terminal deflection of the
P-wave” (44)
PR interval Length between the beginning of the P wave to the beginning of the QRS complex (13)
QT maximum, minimum, dispersion and duration Similar to P wave above.
QT interval is the beginning of the Q wave until the end of the T wave (45).
QT dispersion is the difference between QT maximum and QT minimum (in milliseconds) (45)
Abnormal QT dispersion (QTd) QTd greater than the total of the mean QTd plus two standard deviations of the normotensive group (46)
QTc maximum, minimum, dispersion, duration Similar to P wave above.
QTc = QT interval corrected for heart rate using Bazett’s formula: QT/
√
RR interval (11)
Only Kirbas et al. (12) uses Hodges formula instead to correct for heart rate: [QTc = QT + 1.75 (heart rate – 60)]
QTc prolongation QTc is longer than the mean QTc plus two standard deviations of the normotensive group for each sex (46)
OR
Longer than 440ms for Akintunde et al. (45)
OR
Longer than 430ms in males and longer than 450ms in females for Solanki et al. (47)
OR
Longer than 450ms in males and longer than 460ms in females for Sun et al. (48)
QTcF duration (ms) Uses the Fridericia formula which takes the QT interval and divides it by the cube root of the RR interval to correct
for heart rate (13)
QTfr maximum (ms) Uses Fridericia formula which takes the QT maximum interval and divides it by the cube root of the RR interval to
correct for heart rate (49)
QTc peak Time from start of the QRS complex until the point of a positive T wave peak (50)
Corrected for heart rate using Bazett’s formula (50)
Fragmented QRS QRS complexes that have notches in the R or S wave or an additional R wave or more in two contiguous leads (51)
QRS duration Average of the first deflection from the isoelectric line after the P wave until the J-point (13)
QRS axis Not defined (45)
R wave amplitude Amplitude of R wave (in millivolts) (52)
R wave axis “Net vector of the R wave axis based on the extremity leads” (in degrees) (13)
Poor R wave progression “R wave in the precordial lead V3 ≤ 3mm and R in lead V2 ≤ R in lead V3” (53)
S wave amplitude Amplitude of S wave (in millivolts) (52)
SV1/V2 + RV5/6 Amplitude of S wave in lead V1 or V2 added to the amplitude of R wave in lead V5 or V6 (in millivolts) (45)
T wave maximum, minimum, dispersion, amplitude Similar to P wave above (13)
T wave alternans Changes in the shape, amplitude or timing of T waves or ST segment (54)
T wave axis T wave axis was divided into abnormal and not abnormal T wave axis. An abnormal T wave axis was – 180◦ ≤ T
wave axis < – 15◦ or 105◦ < T wave axis ≤ 180◦ (55)
TpTe Length between peak of T wave to the end of the T wave (13)




TpTe or TpTe(c) divided by QT or QTc for a ratio as a possible “marker of the ventricular heterogeneity of
repolarization” (56)
Ventricular Activation Time (VAT) “First deflection from the isoelectric line following the P wave until the peak of the R wave” (in milliseconds) (13)
J point T peak duration (corrected for heart rate) “Duration of QRS complex offset to peak of the T wave/RR interval. RR interval is the interval between the onset of
one QRS complex to the onset of the next QRS complex, measured in seconds, derived from the heart rate (HR)
as 60/HR” (13)
Ischemic ECG abnormalities “Presence of ST and T wave abnormalities suggestive of ischemia, ischemic T wave changes, abnormal Q/QS
waves, and the presence of left bundle branch block” (57)
C, corrected for heart rate.
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FIGURE 2 | The graphical definition of common ECG wave features seen in this review of 35 articles. QT intervals in numbers 8 to 11 are corrected for heart rate into
QTc intervals by applying a formula such as Bazett’s (QTc = QT/
√
RR interval) (11) or Hodge’s formula [QTc = QT + 1.75 (heart rate – 60)] (12). Note that the two ECG
signal segments (solid and dashed) are collected from the same subject.
longer with increased BP. With the four articles which did not
find significance, there was slightly lower BMI (26.1 to 26.5
vs. 27.4 to 30 for significant articles), but otherwise no clear
differences in age, gender, number of participants with elevated
BPs, number of comorbidities, BP measuring technique or ECG
analysis technique (31, 42, 45, 50). All three articles on QTc
dispersion found that it was significantly greater with higher
BP. QTc prolongation was also significant in all four articles.
Two of the four articles on QTc maximum showed that it was
significantly longer with higher BP. The two articles which did
not find significance either had no participants with hypertension
(11), or the participants were young at 28.2 years old, healthy
without comorbidities, and recently diagnosis in pregnancy (56).
Kirbas et al. did find a significant difference with a young healthy
pregnant population as well, but they only found significance
when they were looking at severe preeclampsia which has a BP
equal or over 160/110 mmHg or systemic symptoms (12). They
did not find significance with mild preeclampsia (12). There were
no significant findings for QTc minimum in three articles. QTc
peak, QTcF duration and QTfr Maximum over 50ms were all
mentioned in two or fewer articles.
Twelve articles studied the QRS complex, as shown in Table D.
Fragmented QRS was significantly more present with elevated BP
in three of three articles. The QRS duration was significant in two
of four articles. The two articles without significance had older
population averages in the 40 s compared to 22.7 years old and
not reported and higher BMI averages at 26.1 and 29.4 compared
to 22.7 and not reported (42, 64). The R wave amplitude was
significantly greater in three of three articles. There were two or
less articles for QRS axis, Q/QS wave abnormality, R wave axis,
poor R wave progression, S wave amplitude and adding S wave to
R wave amplitudes.
Six articles looked at T wave features, as shown in Table E. No
more than two articles investigated T wavemaximum,minimum,
dispersion, amplitude, electrical alternans, T wave axis and T
wave inversion. T wave amplitude was the most notable T wave
feature, and two of two articles found that it was significant for
higher BP.
Seven articles investigated the time from T wave peak to the
end of the T wave (TpTe), as seen in Table F. Note that TpTe was
significantly longer, as BP increased in four of five articles. The
one article that did not find significance had a young average age
of 22.7 years old, population that was recruited to be free from
any comorbidities, the lowest BMI average in the five articles
of 22.7, the lowest percentage of females at 26.3% and only
17.4% participants had prehypertension with no hypertensive
participants in the study (13). Two or fewer articles mentioned
TpTe maximum or variations in TpTe which corrected for heart
rate or divided it by QT or QTc.
Other ECG morphologies are mentioned in Table G. Queen
et al. (57) grouped a number of ECG morphologies into an
“ischemic ECG abnormalities” group. Two articles looked at
ventricular activation time (VAT). One article looked at J point
T peak duration corrected for heart rate. All of these articles
found significant results except for one VAT article. Anigbogu
et al. did not find any significant difference in ST duration
between hypertensive and normotensive participants (33).
Sriratanaviriyakul et al. investigated multiple features such as ST
depression, atrioventricular conduction defects and ventricular
conduction defects, however only found a small significant
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FIGURE 3 | The relationship between atrial and ventricular ECG wave features with BP. LAE, left atrial enlargement; LVH, left ventricular hypertrophy; LVDD, left
ventricular diastolic dysfunction. Note that Ns stands for the number of studies of statistical significance (p < 0.05) while Nns stands for the number of studies of
non-statistical significance. The four features highlighted in red show features that have two or more studies with statistically significant results.
difference in right bundle branch blocks presence in hypertensive
participants compared to normotensive participants (65).
Grouped by Presence or Absence of
Comorbidities and Confounding Factors
Of the 35 articles used in this paper, 26 articles identified
comorbidities or confounders, such as diabetes mellitus,
metabolic syndrome, alcohol consumption, smoking, and obesity
with a mean BMI over 30 kg/m² within their populations. We
compared the ECG wave parameters between articles with and
without comorbidities and confounders.
In the five articles without comorbidities or confounders for
P wave features (56, 58, 62, 66, 67), only P wave dispersion still
looked promising with four of five articles with demonstrating
significant findings (58, 62, 66, 67). QTc dispersion was
significant in two of two articles without comorbidities or
confounders (11, 12). The T wave peak to the end of the T wave
interval (TpTe) was significantly longer in three of three articles
without comorbidities or confounders (11, 12, 56). The most
profound difference in TpTe was 93.1ms for PHT participants
and 67.9ms for NT participants (11). TpTe/QTc ratio was also
significantly different in two of two articles (12, 56). A summary
of grouping ECG features associated with hypertension in terms
of atrium and ventricles is shown in Figure 3. The other ECG
wave parameters were not considered as they did not have
more than one significant result in the group of articles without
comorbidities or confounders.
Special Populations
Articles with pregnant participants [three articles (12, 56, 62)]
and pediatric participants [two articles (66, 67)] are considered
as special populations in this review. No ECG parameters were
investigated by all three articles with pregnant populations
(12, 56, 62). Gazi et al. (56) and Kirbas et al. (62) both
looked at P wave parameters. Kirbas et al. (62) reported
significant P wave dispersion and P wave minimum. Gazi et al.
(56) did not find any significance in its P wave maximum,
minimum, or dispersion. A different article by Kirbas et al. (12),
reported a significant increase in QTc dispersion, maximum, and
duration when normotensive pregnant women were compared
to pregnant women with severe preeclampsia. In comparing
mild preeclampsia with normotensive pregnant women, only
QTc dispersion was significantly increased. Gazi et al. (56) found
significance for QT maximum, but did not find any significance
for QTc maximum. Both Kirbas et al. (12) and Gazi et al. (56)
found that TpTe and TpTe/QT ratio were significantly increased
in pregnant women with pregnancy-induced hypertension when
compared to normotensive pregnant women.
The two pediatric articles measured BP after the participant
rested for 10min and an appropriately sized BP cuff was
used (66, 67). These articles classified normotensive participants
into the 90th percentile for their sex, age and height group,
prehypertensive as between the 90th to 95th percentile, and
hypertensive as above the 95th percentile. Both of the pediatric
population articles only studied P wave dispersion and found that
it was significantly increased as BP increases (66, 67). One of these
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two articles noted that 16.8% of its participants were obese (66),
and the other article did not mention the BMI measurements of
the population (67).
Atrial vs. Ventricular Parameters
Atrial parameters included P wave parameters and PR interval.
Looking at both of these parameters in articles without
comorbidities or confounders, there were six significant results
and six not significant results. It is unclear if atrial parameters
overall change with elevated BP compared to normal BP.
Ventricular parameters included QT/QTc, QRS complex, R wave,
S wave, T wave, and TpTe. Only QT/QTc and TpTe parameters
were available in articles without comorbidities or confounders.
There were 12 significant results and 13 not significant results in
these ventricular parameters. As with atrial parameters, it is also
unclear whether ventricular parameters are significantly changed
by increased in BP. A summary of these atrial and ventricular
parameters without comorbidities or confounders can be found
in Figure 3.
ECG Parameter Estimation
ECG parameter estimation methods are listed in the last column
in Appendix 3. Twenty articles used manual methods, six mixed
manual and automatic computation with software methods, six
used only computed methods and three articles did not specify
how ECG parameters were estimated. Five articles described their
manual methods such as using calipers and a magnifying glass
to identify ECG deflections (12, 63). Fourteen articles stated
they used a “manual” method without further details about
instruments used (56, 68). One article scanned the 12-lead ECG
recording into a computer at 600 dpi and two investigators used
a computer program to manually measure the ECG parameters
on the computer (42). Manual methods were either described as
being done by cardiologists (seven articles), investigators (four
articles), a general practitioner and a cardiologist (one article),
a physician (one article), experts (one article), observers (three
articles) or not specified (three articles). Manual methods had
either two individuals (11 articles), one individual (five articles),
three individuals (one article) or an unspecified number of
individuals estimating ECG parameters (three articles).
The mixed methods noted cardiologists (two articles),
reviewers (two articles), or did not specify (two articles). The
mixed methods either noted only one person manually involved
(three articles) or did not specify how many people were
involved (three articles). In the manual and mixed method
categories, 12 articles noted that the individuals estimating ECG
parameters were blinded to the participants’ clinical statuses and
14 did not report if the individuals were blinded or not. The
computed methods used different automated software programs
for estimating ECG parameters except for a software that was
used by two articles (13, 61) and both Sun et al. articles used the
same software between them (43, 48).
DISCUSSION
In total, 35 articles published from January 1, 2010, to January
1, 2020 were analyzed in this review for using only ECG wave
morphology to identify participants with elevated blood pressure.
Regarding the ECG wave parameters, P wave parameters were
the most commonly investigated feature in our review. These
parameters include P wave maximum, minimum, duration,
prolongation, dispersion, area, terminal force and amplitude
as well as PR interval. Previous studies have shown that P
wave changes predict left atrial enlargement (LAE), which can
occur in various conditions (69). In cases of hypertension, LAE
occurs as a compensatory reaction to decreased left ventricular
compliance as a result of chronically increased left ventricular
pressure, left ventricular hypertrophy, and diastolic dysfunction
(70). However, some literature questions the utility of P wave
morphological analysis for identifying LAE (71, 72).
In our review, P wave dispersion appeared the most promising
for monitoring BP according to the number of studies in
which it was significantly present in cases of higher BP. The
literature supports monitoring P waves; for example, Aksoy
et al. (29) treated 30 participants for hypertensive crises and
noted that P wave parameters could change acutely upon
treatment, finding significant decreases in P wave maximum
and dispersion between the time of presentation and the period
after treatment. In addition, Çimen et al. noted that P wave
dispersion and maximum were significantly present before
cardiac structural changes (73). However, in our review, when
articles with comorbidities and confounders were removed,many
significant P wave parameters were also removed except for
P wave dispersion. The remaining P wave dispersion articles
can be seen in Table 2. It is notable that most of the studies
without comorbidities or confounders were in populations with
children or pregnant women. This wide variety of population
characteristics in only a few studies prevents us from being able
to draw a conclusion about P wave parameters at this time.
There is a large body of research that supports P wave changes
in the presence of various comorbidities and confounders, such
as sex, age, obesity, smoking habit, and diabetes mellitus (36,
43, 74–79). With this in consideration, the participants in Aksoy
et al.’s study had an average BMI of almost 30 kg/m² (29),
and 42% of participants in Çimen et al.’s study smoked (73).
These confounders may have impacted the P wave results.
There are also racial differences; for example, South Asians
have been reported to have reduced P wave dispersion (80).
Furthermore, it is reported that P wave changes only occur
after prolonged exposure to hypertension and the appearance of
complications, such as atrial fibrillation (81, 82). Overall, P waves
may not be dependable for specifically monitoring elevations in
BP, but further studies without comorbidities and confounders
are needed.
There were both two significant and four not significant
results for PR intervals in the six articles that investigated PR
intervals. There was one not significant article involving PR
intervals when articles with comorbidities and confounders were
removed from our review. As with P wave changes, prolonged
PR intervals indicate remodeling of the atria (83). Future studies
without comorbidities or confounders need to additionally
include PR interval investigations.
Our review also considered several ventricular features,
including QTc maximum, minimum, dispersion, duration,
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Gazi et al. (56)







NT: 33.6 ± 8.9ms
NT: 42.1 ± 17.0ms
PIHT: 32.3 ± 10.1ms
PIHT: 60.3 ± 17.7 ms*
0.516
< 0.05
Chávez et al. (66) 656 No Cuff-based NT: 30.1 ± 10.5ms HT: 39.1 ± 11.5ms < 0.001
Chávez et al. (67) 515 No Cuff-based NT: 31.9 ± 9.3ms HT: 39.7 ± 11.6ms < 0.001





QTc Dispersion 2 articles significant
0 article NS
Kirbas et al. (12)







NT: 46.8 ± 10.7ms
NT: 27.2 ± 5.2ms
PIHT: 74.5 ± 11.4 ms*
PHT: 36.1 ± 6.8ms
< 0.001
< 0.001
TpTe Interval 3 articles significant
0 article NS
Gazi et al. (56)







NT: 75.8 ± 8.4ms
NT: 74.1 ± 9.4ms
PIHT: 83.5 ± 7.8ms
PIHT: 97.5 ± 5.9 ms*
0.007
< 0.001
Tanindi et al. (11) 84 No Cuff-based NT: 67.9 ± 8.1ms PHT: 93.1 ± 7.6ms < 0.001
TpTe/QTc Ratio 2 articles significant
0 article NS
Gazi et al. (56)







NT: 0.18 ± 0.02
NT: 0.18 ± 0.01
PIHT: 0.19 ± 0.02
PIHT: 0.23 ± 0.01
0.037
< 0.001
NS, not significant; NT, normotensive; PHT, prehypertensive; PIHT, pregnancy-induced hypertension; HT, hypertensive; ms, milliseconds; STD, standard deviation; NR, not reported.
*Severe preeclampsia group. x̄p = calculated pooled mean of variable x, where x can be BMI or age.
prolongation, peak, QTcF duration, QTfr Maximum, QT
maximum, minimum, dispersion, duration, QRS duration,
fragmented QRS, R wave amplitude, S wave amplitude, T wave
maximum, minimum, dispersion, amplitude, TpTe, TpTe/QT
ratio, and TpTe/QTc ratio. From a pathophysiological point of
view, chronically elevated systemic BP leads to increased left
ventricular pressure, which leads to left ventricular hypertrophy
and interstitial fibrosis (84). These changes to the myocardium
result in heterogenous changes to the action potential and
repolarization duration, which in turn results in increased
dispersion of ventricular ECG features (85).
Of the ventricular features, QT and QTc dispersion,
QTc prolongation, and TpTe appeared promising, exhibiting
significantly longer lengths with elevated BP. As with atrial
features, there are numerous confounders and comorbidities
that may affect ventricular features, such as age, sex, obesity,
diabetes mellitus, obstructive sleep apnea, dynamic exercise, and
electrolyte levels (86–89). When articles containing confounders
were removed, the number of significant articles decreased
and the results are summarized in Figure 3. There were still
consistently a few significant findings for QTc dispersion, TpTe
and TpTe/QTc ratio. These articles can be seen in Table 2. Note
that QT and T wave variables have been reported to be associated
both with hypertension and with hypertension and LVH (90).
Interestingly, Bombelli et al. (91) found that TpTe did not predict
the development of hypertension in a 10-year follow-up study.
It was hypothesized that TpTe may occur from exposure to
hypertension rather than preclude it (91). Fragmented QRS and
R wave amplitude appeared promising as well, but after articles
with comorbidities and confounders were removed, no other
articles investigated these parameters. Some literature indicates
that a significant presence of fragmented QRS is associated
with more prolonged exposure to hypertension, more severe
left ventricular diastolic dysfunction, or LVH (92, 93). R wave
amplitude has been limitedly researched, but noted to not have a
decrease in amplitude during exercise in hypertensive adolescent
boys compared to normotensive adolescent boys (94).
When atrial and ventricular features are grouped, as in
Figure 3, there is no clear evidence that atrial or ventricular
features are significant or not significant with elevated BP when
comorbidities and confounders are removed. This may indicate
that specific ECG wave features may be more affected by elevated
BP rather than groupings of atrial and ventricular features.
However, the amount of data for each feature is too limited to
draw specific conclusions.
The ECG wave parameter trend that was least promising for
significant findings was related to minimal values, such as P wave
minimum, QTcminimum, QTminimum, and T wave minimum.
Of the 13 articles that mentioned minimum values, only one
article found a significant difference in the minimum value.
In consideration of all the articles in our review, 16
articles had one or more comorbidities identified in their
study population. Eleven of these articles had two or more
conditions. Comorbidities such as diabetes (37, 76, 77),
hyperlipidemia (95, 96), and thyroid dysfunction (97) may
affect ECGs and obscure the true effect of hypertension on
ECGs. Future studies comparing normotensive individuals to
individuals with hypertension need comprehensive exclusion
criteria to remove participants with comorbidities from the
study population.
A further consideration is that 10 articles had significant
differences between the age, sex or other variables between the
different BP groups within the studies. There were also 15 articles
which did not report if there were any significant differences
between the different BP groups. Confounders such as differences
in age (38), sex (38), high BMI (40, 41, 87), alcohol use (35) and
smoking (34, 36) are known to affect BP. Future participant pools
would benefit from eliminating differences between BP groups in
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these confounders and limiting alcohol and tobacco use amounts
in the study population.
When looking in the results section the study population
of the articles that showed insignificant results between blood
pressure groups, were often younger, healthier, normotensive or
recently diagnosed with hypertension. Note that all techniques
used for measuring BP and collecting/analyzing ECG signals
were similar between studies that showed significant or
insignificant findings.
BP was measured by cuffed methods in every article in
our review. The one article that also had an invasive, cuffless
BP method, used it to confirm the BP categorization of their
participants into hypertensive or normotensive groups. This
leaves an opportunity for future studies to use invasive BP
measurements to analyse ECG signals as they change with
BP fluctuations.
Special Populations
Of the three articles investigating pregnant populations, the
most promising parameters were TpTe features. Interestingly,
healthy pregnancies have been associated with increased heart
rate, shortened AV conduction, prolonged QTc duration, and
alterations in ventricular depolarization and repolarization (98,
99). Some of these changes do not resolve after delivery (98,
99). There is a theory that spatial changes in the thoracic
cavity (similar to changes that occur with obesity) could cause
changes in ECG parameters as well as hormonal changes, such
as increased sympathetic activity and total body fluid (98). While
there is currently not enough data about the differences between
healthy pregnancies and pregnancies with hypertension, if we
can develop a convenient ECG-only method of monitoring BP,
we may be able to intervene early or prevent hypertensive crises
in pregnancy.
There were two articles with pediatric populations that
showed significant increases in P wave dispersion, but these two
articles may have had a large overlap in their study populations
as they both included participants from the same project pool
of participants (66, 67). In addition, one article included a
participant population that had 16.8% with obesity (66), and
the other article did not disclose the BMIs of their pediatric
population (67). Obesity has been associated with increased P
wave dispersion and duration in adult populations (75, 78). In a
pediatric population, obesity and status as a pediatric athlete were
associated with increased QTc and QT dispersion (68, 100). It is
unclear in the limited pediatric articles if P wave or other ECG
parameters change with elevated BP in pediatric patients.
ECG Parameter Estimating
There was also a variety of manual and computer software
methods for estimating ECG parameters. Manual methods used
one, two, three or an unspecified number of individuals to
estimate ECG parameters. These individuals were described
in various ways such as cardiologists, investigators, general
practitioners, experts, observers, or were not described. This wide
variety is concerning as it is known that ECG interpretations
and the frequency of interpretation errors can differ depending
on the training level of the ECG reader (101–103). Interestingly,
confirmation biases can occur with ECG interpretations when
clinical details about the patient are included (103). Of the 26
articles that mentioned using manual methods, only 12 reported
whether the individuals were blinded to the participants’ clinical
status. This highlights that it is important to consider who will be
estimating the ECG parameters, how much knowledge they have
of the participants, their training level and how many individuals
are needed to minimize biases. The different computer software
packages employed were either used alone or a mix of computer
software and manual reviewing was used. Interestingly, almost
all the computer methods used different software and only two
studies alluded to why their software was chosen. It would be
valuable to know why certain software package were chosen
by the investigators to help evaluate the reliability of the ECG
results. For example, Hassing et al. reported that they used an
algorithm which has been previously used in studies and was
known tomeet all the International Electrotechnical Commission
requirements for amplitude estimation (13). Vaidean et al. noted
their ECG analysis software was common in primary health care
(83). Three articles did not describe how their ECG parameters
were estimated. Consistent reporting and careful consideration
of the manual and/or computer methods used in future articles
is needed.
Considerations for Portable, ECG-Only BP
Monitoring
There is a need for 24-h continuous, accurate, and non-intrusive
monitoring of BP for the general population. Some articles
show that it is possible to integrate lightweight, portable patient
monitoring devices into daily life (104, 105). Increasing the
usability of ECGs will make health surveillance more accessible
in rural and resource-limited settings (106).
The challenge is deciding whether there are ECG parameters
for which there is meaningful data indicating that they can
identify hypertension early in its disease process. Looking at
articles without comorbidities or confounders, four ECG wave
parameters had more than one article finding them significantly
difference with increases in BP. P wave dispersion was the
only atrial features which appeared promising in this review.
Three ventricular features appeared promising involving QTc
dispersion, TpTe and TpTe/QTc ratio. However, there is limited
data as most articles included comorbidities or confounders
that may have affected the results. Further articles investigating
atrial and ventricular feature changes between normotension and
hypertension in otherwise healthy populations are needed. There
can also be investigations intomachine learning with ECG signals
to consider whether meaningful BP data can be obtained from
ECG wave morphology (26–28).
To move the ECG technology forward we sought to
summarize the promising ECG features that are associated
with hypertension, as shown in Table 1. This was carried out
counting in the ECG features that were consistently reported
to be correlated with BP. The visual representations of the
promising ECG features are shown in Figure 4. It can be seen
that P wave dispersion is the difference between the longest and
shortest P wave durations (13, 67). This difference has been
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FIGURE 4 | ECG features associated with hypertension based on this study. It is clear that P wave dispersion, TpTe interval, and QTc interval dispersion are increasing
in subjects with hypertension. Dispersions are calculated from the difference between the maximum and minimum lengths of the feature. This image shows the
normotensive individual as a minimum length and the hypertensive individual as a maximum length to illustrate the longer dispersions in hypertensive individuals. The
green arrows are approximated shorter as the normotensive dispersions are significantly shorter from the results of this review. NT, Normotensive; HT, Hypertensive.
seen to increase in those with hypertension compared to those
with normotension. TpTe is the length of the interval from
the peak of the T wave to the end of the T wave (13, 56). Its
duration is an average of several TpTe estimations. TpTe has
also been seen to increase in length in those with hypertension
compared to those with normotension. Thirdly, QTc dispersion
is the difference between the longest and shortest QTc durations
and it increases in length in those with hypertension. Finally,
TpTe/QTc duration was also listed in Table 1 as increasing with
hypertensive individuals. It was not included in Figure 4 as
it is a calculation from ECG wave morphology than a direct
ECG wave morphology to be visualized. These four ECG wave
features appear the most promising in identifying hypertensive
individuals and would be promising features for future research.
Another consideration related to bringing ECGs into daily
life is the burden of using multiple leads to collect 12-lead ECG
data. There is limited data regarding the leads on which it may
be important to focus for monitoring for ECG changes. There
are discussions about whether using six leads instead of a full
12-lead ECG would decrease the accuracy of QTc dispersion
estimation (99). The one article in our review which used only
one lead (lead III) for QT and QTc estimation did not find
significant ECG changes with elevated BPs (31). Ten other articles
in our review described specific single lead results. However,
with the number of different ECG wave parameters estimated
and the variance in which single leads were reported, further
investigations describing all the leads and their specific findings
are needed.
Devices with limited lead approaches are showing potential.
Smartphones with an additional small handheld device have the
potential to identify atrial fibrillation using a single ECG lead
approach (107). Smartwatches also can capture multiple types
of single lead estimations and possibly provide enough data to
identify ischemic changes such as ST elevations (108). Research
commenting on the specific leads used and comparing leads
would be beneficial for the development of convenient, daily-life
BP monitoring.
A third consideration is the type of activity in which a person is
involved while beingmonitored, whichmay alter the ECG results.
For example, Bhandari et al. found that non-obese young men
exhibited significant changes in heart rate, BP, and QTc interval
after dynamic exercise (88). It would be important for future
studies to investigate if continuous BP monitoring with ECGs
during dynamic activities is relevant for diagnosing hypertension,
or if BP readings during dynamic exercise need to be
left out.
Finally, it is important to investigate the setting of ECG
parameter estimation. For example, increases in heart rate have
been correlated with cardiovascular mortality when measured
in a clinical setting (19). However, when heart rate is taken
in ambulatory settings, the correlation is lost, possibly due to
community confounding factors or a unique attribute of the
office setting, such as sympathetic activation (19). Conversely,
BP measurements taken at home rather than in an office setting
are more correlated with LVH (109). This underlines that it
is important to not only consider ECG parameter estimations
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in clinical settings but also to investigate ECGs in ambulatory
settings to determine whether there are any differences in results.
One limitation of this review is that there may be more
ECG wave parameters in the literature that were not identified
by our original search terms. We chose to filter articles by the
main ECG wave parameters to reduce and focus the number of
articles for the hand search. We used a preliminary literature
search to identify our listed ECG wave parameters. A further
limitation common to research reviews is that articles may only
be published or report findings if there was significance.
Another limitation across the included articles was
inconsistent reporting of comorbidities or confounders.
Therefore, some articles without any reported comorbidities
or confounders, such as obesity, smoking habit, or diabetes
mellitus, may have had a comorbidity or confounder that
was not identified. This is considering that for example in the
world, 8.3% of adults have diabetes (110), 12.5% of adults are
obese (111), and 15.2% of adults smoke tobacco daily (112).
There was also inconsistent reporting of the average duration
of hypertension diagnosis and whether medications were used.
Finally, there were variations in participants’ age and sex, which
may have influenced ECG parameter results (38). These factors
would add a degree of uncertainty as they would in most
research studies.
RECOMMENDATIONS
We found 36 articles for our literature review, 35 articles
were included for our analysis, and between them they
studied a wide variety of ECG wave parameter changes with
BP changes. Currently, there is no well-supported consensus
regarding these parameters. Therefore, our ability to develop
recommendations for specific ECG parameters is limited.
We suggest ways in which future research can address
these concerns.
Based on our literature review of ECG-only BP measurement
and hypertension identification, we recommend the following:
1. Continuing research needs to be conducted with larger
participant sample sizes, clear exclusion and inclusion
criteria, and the use of young, healthy subjects to establish
a more robust relationship between ECG features and BP.
2. Future research studies need to include hypertensive,
prehypertensive, and normotensive populations or the use
of subgroups with a fixed range of BP (e.g., intervals of 5
mmHg for systolic, diastolic, or both) increases to clarify if
there is a linear trend in terms of BP increase.
3. Reporting the duration of hypertension and
prehypertension diagnoses among study participants
will help clarify whether ECG parameters are dependent
on the amount of time a participant has had hypertension
or prehypertension.
4. When researching ECG parameters for BP, there is an
opportunity to collect and report a wide variety of
ECG parameter data to increase the amount of data
available to analyze the significance of the various possible
ECG parameters.
5. Reporting if ECG parameters are estimated using
manual methods or computer software methods
would be important to clarify if different methods are
producing different results or biases. Including the training
background of the manual estimaters (i.e., cardiologist,
general practitioner, etc.), the number of individuals
involved, the individuals’ involvement/understanding of
the study and participants, the computer software used
and the reason the computer software was chosen would
be valuable information for considering the reliability of
reported ECG results.
6. The current understanding of the pathophysiology
underlying ECG wave morphology changes is cardiac
tissue adaptation from chronic exposure to high
BP. There is a need for research studies that follow
participants over time to investigate how ECG parameters
can change and how long it takes for them to show
change. These findings can determine whether ECG
changes occur before or after hypertension is diagnosed
and guide how frequently ECG-only monitoring
could occur.
7. BP prediction models using a combination of ECG
parameters need to be explored. This would give us the
opportunity to predict whomay need early interventions to
prevent hypertension and its disease progression. Artificial
intelligence can play a major role here.
8. There is an opportunity to compare systolic and diastolic
BPs to see if there are significantly different ECG findings
between them. We found only one study in our review
which looked at SBP and DBP separately (13). This
can further our understanding if ECGs can differentiate
normotensive vs. elevated BPs for both systolic and
diastolic settings.
9. Consistent listing or exclusion of ECG confounders, such
as hypertension medication, smoking habit, alcohol use,
and BMI can help with the interpretation of significant
ECG results.
10. Future research needs to consider investigating pregnant
and pediatric populations. If hypertension can be identified
early in life or during significant life events such as
pregnancy, intervention can be implemented early and
disease progression can be slowed or prevented.
11. Investigations need to compare specific ECG changes due
to hypertension to changes to the heart from athletic
activities. We are aware of one study that did not find
PQ, QRS, or QT parameters to be different between these
groups (113).
12. Limiting the number of ECG electrodes used for
data collection to 1-, 3-, or 6-lead ECGs (compared
to a full standard 12-lead ECG) would lead to an
understanding if we can obtain reliable data from less
leads. With less leads, more convenient and portable
ECG signal collection devices may be used to monitor
BP. Future articles reporting the results from all 12
leads would provide a way to investigate if one or
a few leads would be more reliable to focus on for
monitoring BP.
Frontiers in Medicine | www.frontiersin.org 13 December 2020 | Volume 7 | Article 583331
Bird et al. Assessment of Hypertension Using Electrocardiogram
13. In future studies using ECG parameters to predicting
BP, it will be important to provide a thorough analysis
including the accuracy of identifying or predicting
hypertension, the agreement between the BP measurement
using a gold standard and estimated BP utilizing ECG
signal, and the correlation between ECG parameters and
BP measurement.
CONCLUSIONS
This review summarized the literature on the use of only ECG
signals to monitor blood pressure or identify hypertension
from January 1, 2010, to January 1, 2020. In the 35 analyzed
articles, P wave dispersion, QT and QTc dispersion, QTc
prolongation, fragmented QRS, R wave amplitude, and TpTe
were found to be promising as they were significantly associated
with higher systolic or diastolic blood pressure. However,
there were limited articles for each ECG wave parameter.
When articles with comorbidities and confounders for ECG
changes were removed, one atrial feature of P wave dispersion
was often significant with higher BPs. Three ventricular
features of QTc dispersion, TpTe interval, and TpTe/QTc ratio
were found to be promising as well. However, most articles
without comorbidities or confounders were in pediatric or
pregnant populations. With this wide variety of participant
characteristics, further data is needed before conclusions about
the usefulness of ECG wave morphology for monitoring BP can
be made.
ECGs have the potential to provide a convenient and long-
term way to monitor BP in the future with the support of further
research and the growth of smart personal devices. We have
made 13 recommendations for future ECG-only BP monitoring
studies. It is important for further research to include pediatric
and pregnant populations as these populations would benefit
from early monitoring and intervention.
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